PT  - JOURNAL ARTICLE
AU  - Gel, Esma S.
AU  - Jehn, Megan
AU  - Lant, Timothy
AU  - Muldoon, Anna R.
AU  - Nelson, Trisalyn
AU  - Ross, Heather M.
TI  - COVID-19 Healthcare Demand Projections: Arizona
AID  - 10.1101/2020.05.13.20099838
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.13.20099838
4099  - http://medrxiv.org/content/early/2020/05/16/2020.05.13.20099838.short
4100  - http://medrxiv.org/content/early/2020/05/16/2020.05.13.20099838.full
AB  - Beginning in March 2020, the United States emerged as the global epicenter for COVID-19 cases. In the ensuing weeks, American jurisdictions attempted to manage disease spread on a regional basis using non-pharmaceutical interventions (i.e. social distancing), as uneven disease burden across the expansive geography of the United States exerted different implications for policy management in different regions. While Arizona policymakers relied initially on state-by-state national modeling projections from different groups outside of the state, we sought to create a state-specific model using a mathematical framework that ties disease surveillance with the future burden on Arizona’s healthcare system. Our framework uses a compartmental system dynamics model using an SEIRD framework that accounts for multiple types of disease manifestations for the COVID-19 infection, as well as the observed time delay in epidemiological findings following public policy enactments. We use a bin initialization logic coupled with a fitting technique to construct projections for key metrics to guide public health policy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was used for this project.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is publicly available on https://covidtracking.com/ and the https://www.azdhs.gov/preparedness/epidemiology-disease-control/infectious-disease-epidemiology/covid-19/dashboards/index.php.